SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: M. LaMancha who wrote (155)6/9/1997 12:53:00 AM
From: Josh C. Pleasure, M.D.   of 371
 
If you're talking about total number of nuclear medicine scans, I have no idea what percentage is WBC scanning currently.

LeukoScan will be extremely useful clinically since it is able to detect bone infections much more quickly and simply than WBC scanning. Please click on my name and read my posts on IMMU dating back over the last year or so for more information.

If I had to guess at the number of LeukoScans that will be performed in the US in the year 2000, I'd say over 100,000. I'd expect the company to get about $400 to 500 net for each one (assuming they get 50% of what patients are billed). These are just guesses and may have no basis in reality.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News